Compass Therapeutics CMPX
NASDAQ CMPX
$1.04 -0.06 (-5.45%)
At close: Sep 30, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Compass Therapeutics' Liabilities and Shareholders Equity came in at $190.17 million for Q2 2026, up 63.0% from $116.7 million a year earlier but down 7.3% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Compass Therapeutics' Liabilities and Shareholders Equity was $219.59 million, up 56.4% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $140.4 million in FY2024 (-10.5%), $156.88 million in FY2023 (-21.4%), $199.65 million in FY2022 (+29.8%) and $153.76 million in FY2021 (+196.2%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $34.9 million (Q3 2021) to $231.26 million (Q3 2025).
  • Year-over-year, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 20.5% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2022 (growth of 266.3%), and the weakest in Q2 2025 (a decline of 25.0%).
  • Business Quant data shows CMPX's Liabilities and Shareholders Equity at $205.17 million (Q1 2026), $219.59 million (Q4 2025) and $231.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 201.06 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 135.12 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 115.83 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 27.42 Bn
10 Compass Therapeutics 198.10 Mn 198.10 Mn - 190.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.17 Mn
Mar 31, 2026 205.17 Mn
Dec 31, 2025 219.59 Mn
Sep 30, 2025 231.26 Mn
Jun 30, 2025 116.70 Mn
Mar 31, 2025 131.45 Mn
Dec 31, 2024 140.40 Mn
Sep 30, 2024 149.15 Mn
Jun 30, 2024 155.61 Mn
Mar 31, 2024 161.14 Mn
Dec 31, 2023 156.88 Mn
Sep 30, 2023 170.04 Mn
Jun 30, 2023 179.18 Mn
Mar 31, 2023 187.98 Mn
Dec 31, 2022 199.65 Mn
Sep 30, 2022 127.84 Mn
Jun 30, 2022 140.26 Mn
Mar 31, 2022 146.56 Mn
Dec 31, 2021 153.76 Mn
Sep 30, 2021 34.90 Mn
API Access

Compass Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CMPX&period=max&api_key=YOUR_API_KEY